Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-029959
Filing Date
2020-10-30
Accepted
2020-10-30 17:47:43
Documents
1
Period of Report
2020-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3874
  Complete submission text file 0000899243-20-029959.txt   5238
Mailing Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005
Business Address
BERGER FRANKLIN M (Reporting) CIK: 0001273885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39661 | Film No.: 201278459

Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Issuer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations